Atrial fibrillation
Audience: Patients and providers
Status: Clinical guide · patient + provider
Last updated: 2026-03-09
1. Clinical overview
Atrial fibrillation is a supraventricular arrhythmia defined by chaotic atrial activity, irregular ventricular response, and a management framework centered on stroke prevention, symptom control, and comorbidity treatment.
2. Common causes and risk factors
- Disorganized atrial electrical activity from structural/electrophysiologic remodeling.
- Risks: age, hypertension, obesity, OSA, valvular disease, thyroid disorders.
3. Typical symptoms
- Palpitations, fatigue, dyspnea, exercise intolerance; some patients asymptomatic.
4. Diagnosis and evaluation
- Confirm diagnosis with guideline-based history, exam, and indicated testing.
- Screen for severity, complications, and high-risk comorbid conditions.
- Identify social or access barriers that could affect treatment success.
5. Treatment (non-pharmacologic)
- Weight reduction, OSA treatment, alcohol moderation, and trigger reduction.
- Shared decision-making around stroke prevention and rhythm goals.
6. Treatment (pharmacologic)
- Anticoagulation commonly uses apixaban, rivaroxaban, edoxaban, dabigatran, or warfarin depending on valve status, renal function, and stroke-risk profile.
- Rate control often uses metoprolol, carvedilol, diltiazem, or verapamil; digoxin may be useful in selected sedentary or heart-failure patients.
- Rhythm strategies may involve flecainide, propafenone, dofetilide, sotalol, or amiodarone depending on structural heart disease and safety constraints.
7. Monitoring and follow-up
- Stroke/bleeding risk, heart rate/rhythm burden, renal function, adherence.
8. Practical counseling points
- Give patients a clear “what to do today / when to call / when to seek urgent care” plan.
- Use teach-back to confirm understanding of treatment goals and medication instructions.
- Simplify regimens when possible to improve adherence and outcomes.
9. Red flags and escalation
- Escalate care urgently for severe or rapidly worsening symptoms.
- Reassess diagnosis if expected response does not occur within the anticipated timeline.
10. Guideline references
- ACC/AHA/ACCP/HRS atrial fibrillation guideline.
- ESC atrial fibrillation recommendations.
- CHEST antithrombotic guidance.
Note: Educational guide only; not a substitute for individualized medical care.
